Aspen Aerogels (ASPN)
NYSE:ASPN

Aspen Aerogels (ASPN) Stock Forecast & Price Target

321 Followers
See the Price Targets and Ratings of:

ASPN Analyst Ratings

Strong Buy
3Ratings
3 Buy
0 Hold
0 Sell
Based on 3 analysts giving stock ratings to
Aspen
Aerogels
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ASPN Stock 12 Months Forecast

Average Price Target

$29.33
▲(151.87% Upside)
Based on 3 Wall Street analysts offering 12 month price targets for Aspen Aerogels in the last 3 months. The average price target is $29.33 with a high forecast of $45.00 and a low forecast of $20.00. The average price target represents a 151.87% change from the last price of $11.65.
Highest Price Target$45.00Average Price Target$29.33Lowest Price Target$20.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Upgrade Banner
Benchmark Co.
$29.00
Buy
149.03%
Upside
Reiterated
Aspen Aerogels (ASPN) PT Lowered to $29 at BenchmarkBenchmark analyst Douglas Becker lowered the price target on Aspen Aerogels (NYSE: ASPN) to $29.00 (from $36.00) while maintaining a Buy rating.
B.Riley Financial
$34.00
Buy
191.97%
Upside
Reiterated
Aspen Aerogels price target lowered to $34 from $44 at B. RileyAspen Aerogels price target lowered to $34 from $44 at B. Riley
Craig-Hallum
$32.00
Buy
174.80%
Upside
Reiterated
Aspen Aerogels price target lowered to $32 from $50 at Craig-HallumAspen Aerogels price target lowered to $32 from $50 at Craig-Hallum
EF Hutton
$18.00
Buy
54.57%
Upside
Reiterated
EF Hutton Thinks Aspen Aerogels' Stock is Going to Recover
Piper Sandler
$59.00
Buy
406.66%
Upside
Reiterated
Aspen Aerogels (ASPN) PT Lowered to $59 at Piper SandlerPiper Sandler analyst Alexander Potter lowered the price target on Aspen Aerogels (NYSE: ASPN) to $59.00 (from $68.00) while maintaining a Overweight rating.
Stocks with the Highest Top Analyst Consensus in the Basic Materials Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Basic Materials sector that are highly recommended by Top Performing Analysts.

ASPN Financial Forecast

ASPN Earnings Forecast
Next quarter’s earnings estimate for ASPN is -$0.30 with a range of -$0.45 to -$0.16. The previous quarter’s EPS was -$0.75. ASPN beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 51.70% of the time in the same period. In the last calendar year ASPN has Underperformed its overall industry.
Next quarter’s earnings estimate for ASPN is -$0.30 with a range of -$0.45 to -$0.16. The previous quarter’s EPS was -$0.75. ASPN beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 51.70% of the time in the same period. In the last calendar year ASPN has Underperformed its overall industry.
ASPN Sales Forecast
Next quarter’s sales forecast for ASPN is $57.73M with a range of $52.50M to $60.00M. The previous quarter’s sales results were $36.71M. ASPN beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 54.91% of the time in the same period. In the last calendar year ASPN has Underperformed its overall industry.
Next quarter’s sales forecast for ASPN is $57.73M with a range of $52.50M to $60.00M. The previous quarter’s sales results were $36.71M. ASPN beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 54.91% of the time in the same period. In the last calendar year ASPN has Underperformed its overall industry.
ASPN Analyst Recommendation Trends
In the current month, ASPN has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The ASPN average analyst price target in the past 3 months is $29.33
In the current month, ASPN has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The ASPN average analyst price target in the past 3 months is $29.33

ASPN Stock Forecast FAQ

What is ASPN’s average 12-month price target, according to analysts?
Based on analyst ratings, Aspen Aerogels’s 12-month average price target is $29.33.
    What is ASPN’s upside potential, based on the analysts’ average price target?
    Aspen Aerogels has 151.87% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is ASPN a Buy, Sell or Hold?
          Aspen Aerogels has a conensus rating of Strong Buy which is based on 3 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Aspen Aerogels’s price target?
            The average price target for Aspen Aerogels is $29.33. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $45.00 ,the lowest forecast is $20.00. The average price target represents 151.87% Increase from the current price of $11.645.
              What do analysts say about Aspen Aerogels?
              Aspen Aerogels’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 3 Wall Streets Analysts.

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis